xRead - Nasal Obstruction (September 2024) Full Articles

20426984, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.23262, Wiley Online Library on [02/01/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

448

KUANetal.

1896. Lombard M, Michel G, Rives P, Moreau A, Espitalier F, Malard O. Extranodal non-Hodgkin lymphoma of the sinonasal cavities: a 22-case report. Eur Ann Otorhinolaryn gol Head Neck Dis . 2015;132(5):271-274. https://doi.org/10.1016/ j.anorl.2015.08.015 1897. Quraishi MS, Bessell EM, Clark DM. Aggressive sino-nasal non-Hodgkin’s lymphoma diagnosed in Nottinghamshire, UK, between 1987 and 1996. Clin Oncol . 13(4):269 272. 1898. He L, Zou Y, Tang X, et al. Survival trends for extranodal NK/T-cell lymphoma, nasal type from different anatom ical sites: a population-based study. Ann Transl Med . 2021;9(10):849. https://doi.org/10.21037/atm-21-1748 1899. Wu RY, Liu K, Wang WH, et al. Patterns of primary tumor invasion and regional lymph node spread based on magnetic resonance imaging in early-stage nasal NK/T-cell lymphoma: implications for clinical target volume definition and prognos tic significance. Int J Radiat Oncol Biol Phys . 2017;97(1):50-59. https://doi.org/10.1016/j.ijrobp.2016.09.013 1900. Niu SQ, Yang Y, Li YY, et al. Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lym phoma. Chin J Cancer . 2016;35(5):34. https://doi.org/10.1186/ s40880-016-0096-0 1901. Michot JM, Mazeron R, Danu A, et al. Concurrent Etopo side, Steroid, High-dose Ara-C and Platinum chemother apy with radiation therapy in localised extranodal natu ral killer (NK)/T-cell lymphoma, nasal type. Eur J Can cer . 2015;51(16):2386-2395. https://doi.org/10.1016/j.ejca.2015. 07.009 1902. Youssef YB, Bougmiza I, Bouabid Z, et al. Nasopharyn geal/nasal type NK/T lymphoma: analysis of 23 cases and current review of the literature. Kulak Burun Bogaz Ihtis Derg . 2012;22(5):275-283. https://doi.org/10.5606/kbbihtisas. 2012.053 1903. Kim SJ, Kim BS, Choi CW, et al. Treatment outcome of front-line systemic chemotherapy for localized extran odal NK/T cell lymphoma in nasal and upper aerodigestive tract. Leuk Lymphoma . 2006;47(7):1265-1273. https://doi.org/ 10.1080/10428190600565651 1904. Aviles A, Diaz NR, Neri N, Cleto S, Talavera A. Angio centric nasal T/natural killer cell lymphoma: a single cen tre study of prognostic factors in 108 patients. Clin Lab Haematol . 2000;22(4):215-220. https://doi.org/10.1046/j.1365 2257.2000.00307.x 1905. Rodriguez J, Romaguera JE, Manning J, et al. Nasal type T/NK lymphomas: a clinicopathologic study of 13 cases. Leuk Lymphoma . 2000;39(1-2):139-144. https://doi.org/ 10.3109/10428190009053547 1906. Sakata K, Hareyama M, Ohuchi A, et al. Treatment of lethal midline granuloma type nasal T-cell lymphoma. ActaOncol . 1997;36(3):307-311. https://doi.org/10.3109/02841869709001268 1907. Senan S, Symonds RP, Brown IL. Nasal peripheral T-cell lym phoma: a 20-year review of cases treated in Scotland. Clin Oncol . 1992;4(2):96-100. 1908. Bernstein JM, Montgomery WW, Balogh K. Metastatic tumors to the maxilla, nose, and paranasal sinuses. Laryn goscope . 1966;76(4):621-650. https://doi.org/10.1288/00005537 196604000-00003

Network study. BMCCancer . 2006;6(118):118. https://doi.org/ 10.1186/1471-2407-6-118 1883. Alexiou C, Kau RJ, Dietzfelbinger H, et al. Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts. Cancer . 1999;85(11):2305-2314. 1884. Patel TD, Vazquez A, Choudhary MM, Kam D, Baredes S, Eloy JA. Sinonasal extramedullary plasmacytoma: a population based incidence and survival analysis. Int Forum Allergy Rhinol . 2015;5(9):862-869. https://doi.org/10.1002/alr.21544 1885. Gong Y, Pu W, Jin H, et al. Quantitative proteomics of CSF reveals potential predicted biomarkers for extranodal NK-/T-cell lymphoma of nasal-type with ethmoidal sinus metastasis. Life Sci . 2018;198:94-98. https://doi.org/10.1016/j. lfs.2018.02.035 1886. Tababi S, Kharrat S, Sellami M, et al. Extranodal NK/T-cell lymphoma, nasal type: report of 15 cases. Eur Ann Otorhino laryngol Head Neck Dis . 2012;129(3):141-147. https://doi.org/10. 1016/j.anorl.2011.08.004 1887. Lin CW, Yang JY, Chuang YC, Chen YH, Albitar M, Hsu SM. Presence of restricted killer immunoglobulin-like receptor repertoire and monoclonal T-cell receptor gamma rearrange ment as evidence of mixed NK/T-cell differentiation in a subset of sinonasal lymphomas. Lab Invest . 2003;83(1):55-64. https://doi.org/10.1097/01.Lab.0000047491.62596.A3 1888. Altemani A, Barbosa AC, Kulka M, et al. Characteristics of nasal T/NK-cell lymphoma among Brazilians. Neoplasma . 2002;49(1):55-60. 1889. Takahashi N, Miura I, Chubachi A, Miura AB, Nakamura S. A clinicopathological study of 20 patients with T/natural killer (NK)-cell lymphoma-associated hemophagocytic syndrome with special reference to nasal and nasal-type NK/T-cell lym phoma. Int J Hematol . 2001;74(3):303-308. https://doi.org/10. 1007/BF02982065 1890. Yang Y, Gau JP, Chang SM, Lin TH, Ho KC, Young JH. Malig nant lymphomas of sinonasal region, including cases of poly morphic reticulosis: a retrospective clinicopathologic analysis of 34 cases. Zhonghua Yi Xue Za Zhi . 1997;60(5):236-244. 1891. Kanavaros P, Briere J, Emile JF, Gaulard P. Epstein-Barr virus in T and natural killer (NK) cell non-Hodgkin’s lymphomas. Leukemia . 1996;10(Suppl. 2):S84-S87. 1892. Van Gorp J, De Bruin PC, Sie-Go DM, et al. Nasal T cell lymphoma: a clinicopathological and immunophenotypic analysis of 13 cases. Histopathology . 1995;27(2):139-148. https:// doi.org/10.1111/j.1365-2559.1995.tb00022.x 1893. Kojima M, Hosomura Y, Kurabayashi Y, et al. Malig nant lymphomas of the nasal cavity and paranasal sinuses. A clinicopathologic and immunohistochemical study. Acta Pathol Jpn . 1992;42(5):333-338. https://doi.org/10.1111/j.1440 1827.1992.tb02882.x 1894. Weiss LM, Gaffey MJ, Chen YY, Frierson HF. Frequency of Epstein-Barr viral DNA in “Western” sinonasal and Waldeyer’s ring non-Hodgkin’s lymphomas. Am J Surg Pathol . 1992;16(2):156-162. https://doi.org/10.1097/00000478 199202000-00008 1895. Shikama N, Ikeda H, Nakamura S, et al. Localized aggres sive non-Hodgkin’s lymphoma of the nasal cavity: a survey by the Japan Lymphoma Radiation Therapy Group. Int J Radiat Oncol Biol Phys . 2001;51(5):1228-1233. https://doi.org/10.1016/ s0360-3016(01)01800-4